Navigation Links
QIAGEN and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals With Latent Infection
Date:1/9/2012

Tools for rapid diagnosis, prevention and therapy are urgently needed to sustainably reduce the global risk. The WHO has set up a strategic program to dramatically reduce the global burden of TB by 2015, for example, by supporting the development of new tools and enabling their timely and effective use.

* WHO: 2011/2012 Tuberculosis Global Facts (http://www.who.int/tb/publications/2011/factsheet_tb_2011.pdf)

About Max Planck Institute for Infection Biology:

The MPIIB was founded in 1993. The Institute commenced operation in a provisional laboratory facility with a small group of scientists, greatly expanded over the years, and relocated to a dedicated facility in summer 2000. It is located in the heart of Berlin on the historical Charité medical campus, where Robert Koch, Paul Ehrlich and Emil Behring made their important discoveries, pioneering the field of infection research, in close proximity to the German Parliament and the newly constructed government offices. The choice of location was intended to support the goal of the Institute to research infectious diseases in close collaboration with universities and clinical units. Further information about the MPIIB can be found at http://www.mpiib-berlin.mpg.de/home.html.

About QIAGEN:

QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make these isolated biomolecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. QIAGEN provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and appli
'/>"/>

SOURCE QIAGEN N.V.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. QIAGEN to Develop New Companion Diagnostic for Compound in Clinical Trials for Blood Cancers
2. QIAGEN and Abbott Enter Into Agreement on Molecular Tests for HIV, HCV and HPV
3. QIAGEN and Roche Settle Dispute Over Distribution Agreement for TheraScreen Companion Diagnostics
4. QIAGEN Acquires Comprehensive Portfolio of Molecular Food Safety Tests
5. QIAGEN Acquires Exclusive Licence for Key PI3K gene
6. QIAGENs New Product Line, QIAsafe(R) DNA Blood, has Been Co-Developed With Biomatrica and is Based on Biomatricas SampleMatrix(R) Technology
7. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11
8. Plexus Awarded Development Contract With QIAGEN
9. QIAGEN and Chittaranjan National Cancer Institute Partner to Establish First Large-Scale Cervical Cancer Screening Program in Kolkata
10. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Fourth Quarter and Year-End 2008 Financial Results Call Set for February 10
11. QIAGEN Welcomes 3,000th Employee in 20th year of U.S. Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... As the weather warms, women everywhere are waiting for the ... make a statement with fashion, many change their makeup to ... mixes makeup and sweat to produce, and increase acne breakouts. ... warmer months, Adult Acne treatment , Probiotic Action shares ... to deter breakouts. , Recently, an article from ...
(Date:5/16/2013)... NEW YORK , May 16, ... a new market research report is ...   Competitor Analysis: ... Biosuperiors http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical ...   The ...
(Date:5/16/2013)... BioInformatics LLC New Market Report – ... Current and Future Opportunities (13-004) , With barriers ... primary cells market continues to increase. In this study, ... often, how satisfied scientists are with commercially available primary ... rate. ,  , Additionally, terminally differentiated cells can ...
(Date:5/16/2013)... 2013 Dr. Stephen Y. Chou, Founder ... “Nanoimprint Lithography and Applications” at IEEE Nano 2013 in ... in 1995 by Chou, is becoming one of the ... combination of sub-10 nm resolution, large area, and low ... both R&D and manufacturing in a broad range of ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 2BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 3Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013 2
... FRANKLIN LAKES, N.J., March 27 BD (Becton,Dickinson ... global medical technology,company, and Direct Relief International, a ... joint volunteer,initiative to strengthen healthcare in Ghana. A ... to Ghana for three weeks and work side-by-side,with ...
... Siemens Will Showcase Its Portfolio of Cardiovascular ... Healthcare, (http://www.usa.siemens.com/healthcare ) will demonstrate how its ... are helping,to "Bring a New Rhythm to ... of the American College of Cardiology (ACC) ...
... Aimed at Developing New Screening Methods and Holds Significant, Potential for Early ... ... Killer, - Biomarker Project holds significant potential for new screening ... the disease before even the ...
Cached Biology Technology:BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana 2BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana 3Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 2Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 3Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 4Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 5Lustgarten Foundation Announces $1.25 Million Commitment to Pancreatic Cancer Biomarker Development Project 2Lustgarten Foundation Announces $1.25 Million Commitment to Pancreatic Cancer Biomarker Development Project 3
(Date:5/16/2013)... years old give unprecedented insight into the evolutionary ... most species-rich groups among the modern bony fishes. ... from the Division of Paleontology and Geobiology at ... Ludwig-Maximilians-Universitaet (LMU) in Munich / Germany have completed ... assign to the group of bony fishes that ...
(Date:5/16/2013)... in Cameroon and the manager of San Diego Zoo ... prestigious Whitley award. The Whitley award is an ... because it celebrates the extraordinary achievements of some of ... Abwe was selected for the award due to his ... and its wildlife inhabitants., HRH The Princess Royal, the ...
(Date:5/15/2013)... in moderating gout risk, new research reveals that vitamin ... acid (urate) levels to a clinically significant degree in ... in combination with allopurinol, appears to have a weak ... according to the results published in the American College ... , Gout is an inflammatory arthritis that causes ...
Breaking Biology News(10 mins):Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Vitamin C does not lower uric acid levels in gout patients 2
... Nov. 1, 2011Researchers at St. Michael,s Hospital have identified ... They also identified two possible treatments to prevent ... the development of new drugs to treat heart attacks ... Ni, found that the same kind of blood-clotting in ...
... people can exchange information instantaneously in the digital age, ... freely and rapidly exchange genetic material related to human ... gene transfer (HGT). In a paper appearing in ... by Eric Alm of MIT,s Department of Civil and ...
... Chinese Academy of Sciences found one new species, Aleurodaphis sinojackiae ... forms leaf galls on Jack trees ( Sinojackia xylocarpa ) and is ... ( Hemiptera , Aphididae , Hormaphidinae ). The ... . Aleurodaphis was established in 1917 by van der ...
Cached Biology News:Researchers pinpoint possible new cause for unexplained miscarriages 2MIT: Bacteria may readily swap beneficial genes 2MIT: Bacteria may readily swap beneficial genes 3